Daily Market Updates: Novo Nordisk shares slide after guidance disappoints investors

S&P 5007,600.50▲1.5% Nasdaq25,913.90▲2.1% Dow53,178.41▲1.3% Russell 2K2,981.91▲1.7% 10-Yr4.69%−6bp VIX15.86−0.13 WTI$80.00▼5.5% Gold$4,106.70▲1.4% EUR/USD1.151▼0.1% BTC$64,041▲0.9% Nikkei64,362▲4.0%

At close · Mon, Aug 3, 2026

Earnings

Home›Earnings›Guidance›Novo Nordisk shares slide after guidance disappoints i…

Novo Nordisk shares slide after guidance disappoints investors

Reported · Written up by our desk · Guidance

Novo Nordisk shares fell after investors reacted negatively to its guidance, signaling disappointment despite an improved outlook.

CNBC Earnings reports the company raised its financial outlook as it seeks to keep pace in the fast growing GLP-1 market.

The update comes as Novo Nordisk tries to catch up with rival Eli Lilly in the category.

← Newer storyMortgage groups call the ROAD to Housing Act a step toward affordabil…Older story →Runaway online rumours spur 72,000 migrants to Ceuta border

More like this

EarningsMeta declines to outline 2027 capex as investors weigh AI spending

EarningsChevron targets lower-end 2026 organic CapEx range after efficiency gains

EarningsBig Tech earnings show AI demand holding up despite infrastructure squeeze

EarningsJLL raises 2026 adjusted EPS guidance on strong first-half momentum

EarningsApple stock falls as iPhone maker guides below views

Sources

CNBC EarningsNovo Nordisk shares slide after guidance disappoints investors

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.